Inactive Instrument

Human Genome Sciences Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

12-07-26	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
12-07-16	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

12-07-26	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
12-07-16	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE
12-07-16	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	RE
12-07-15	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	RE
12-07-03	GlaxoSmithKline plc : GSK lines up nominees for Human Genome board	RE
12-06-29	GlaxoSmithKline plc : GSK further extends $2.6 billion Human Genome offer	RE
12-06-08	GlaxoSmithKline plc : GSK extends its $2.6 billion offer for Human Genome	RE
12-06-01	GlaxoSmithKline plc : Court denies request to curb Human Genome takeover defense	RE
12-05-31	Genmab A/S : Exclusive: GlaxoSmithKline eyes replacing Human Genome board	RE
12-05-30	GlaxoSmithKline plc : Exclusive: GSK eyes replacing Human Genome board	RE
12-05-23	GlaxoSmithKline plc : GSK to drop Human Genome bid if "poison pill" stands	RE
12-05-09	SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	RE
12-05-02	Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	RE

12-08-03	Human Genome Sciences : ANNOUNCES REQUIRED OFFER TO REPURCHASE IN RESPECT OF ITS 3.00% CONVERTIBLE SENIOR NOTES DUE 2018	PU
12-07-26	Human Genome Sciences : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.	PR
12-07-19	Human Genome Sciences : Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breaches of Fiduciary Duty	BU
12-07-17	Human Genome Sciences : Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.	PR
12-07-17	Human Genome Sciences : Ryan & Maniskas, LLP Announces Investigation of Human Genome Sciences Inc.	BU

12-07-25	GlaxoSmithKline plc : GlaxoSmithKline-T2 inférieur aux attentes, baisse du titre
12-07-16	GSK rachète Human Genome pour 3,0 milliards de dollars
12-07-16	GSK annonce le rachat de Human Genome pour $3,0 milliards
12-07-16	Human Genome : grimpe avec la nouvelle offre de GSK.
12-07-16	Wall Street ouvre en léger recul, mais Citi monte

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-0.92%	-1.67%	+1.23%	+18.22%	50.47B
REVOLUTION MEDICINES, INC.	-6.00%	-0.75%	+447.48%	+524.26%	44.56B
IQVIA HOLDINGS INC.	-0.24%	+0.74%	+37.18%	+16.57%	43.08B
BEONE MEDICINES AG	-1.55%	-2.07%	+19.83%	+73.63%	41.7B
CELLTRION, INC.	-0.31%	-0.83%	+19.47%	+48.24%	33.21B
MEDPACE HOLDINGS, INC.	-1.79%	-3.24%	+26.32%	+121.63%	16.77B
ASCENDIS PHARMA A/S	-0.58%	-2.12%	-	-	16.28B
EUROFINS SCIENTIFIC SE	-0.55%	-1.77%	+10.74%	+26.60%	14.58B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.66%	-1.25%	+78.49%	+39.02%	13.92B
Average	-1.51%	-1.39%	+80.09%	+108.52%	30.51B
Weighted average by Cap.	-1.71%	-1.21%	+95.89%	+126.36%